THE EXPRESSION OF ANDROGEN RECEPTOR SPLICE VARIANT 7 AT RADICAL PROSTATECTOMY PREDICTS THE RISK OF PROGRESSION IN UNTREATED NON-METASTATIC PROSTATE CANCER PATIENTS

被引：0
|
作者：
Maggi, Martina
Sciarra, Alessandro
Salciccia, Stefano
Nicolai, Alice
Tortorella, Elisabetta
Giantulli, Sabrina
Magliocca, Fabio Massimo
Silvestri, Ida
Taglieri, Ludovica
Cattarino, Susanna
Scarpa, Susanna
机构：
来源：
JOURNAL OF UROLOGY | 2022年 / 207卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PD46-01
引用
收藏
页码：E788 / E788
页数：1
相关论文
共 50 条
  • [31] Long-term risk of metastatic progression of prostate cancer following radical prostatectomy
    Stephenson, AJ
    Eastham, JA
    Kattan, MW
    Bianco, FJ
    Dotan, ZA
    Scardino, PT
    [J]. JOURNAL OF UROLOGY, 2006, 175 (04): : 210 - 210
  • [32] Improved Androgen Receptor Splice Variant 7 Detection Using a Highly Sensitive Assay to Predict Resistance to Abiraterone or Enzalutamide in Metastatic Prostate Cancer Patients
    Maillet, Denis
    Allioli, Nathalie
    Peron, Julien
    Plesa, Adriana
    Decaussin-Petrucci, Myriam
    Tartas, Sophie
    Ruffion, Alain
    Crouzet, Sebatien
    Rimokh, Ruth
    Gillet, Pierre-Germain
    Freyer, Gilles
    Vlaeminck-Guillem, Virginie
    [J]. EUROPEAN UROLOGY ONCOLOGY, 2021, 4 (04): : 609 - 617
  • [33] Androgen receptor inhibitor treatments: Cardiovascular adverse events and comorbidity considerations in patients with non-metastatic prostate cancer
    Morgans, Alicia K.
    Shore, Neal
    Cope, Diane
    McNatty, Andrea
    Moslehi, Javid
    Gomella, Leonard
    Sartor, Oliver
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (01) : 52 - 62
  • [34] LUTEOLIN SUPPRESSES ANDROGEN RECEPTOR SPLICE VARIANT 7 EXPRESSION VIA MIRNA RECRUITMENT IN CASTRATION-RESISTANT PROSTATE CANCER
    Naiki, Taku
    Naiki-Ito, Aya
    Etani, Toshiki
    Iida, Keitaro
    Ando, Ryosuke
    Nagai, Takashi
    Kawai, Noriyasu
    Takahashi, Satoru
    Yasui, Takahiro
    [J]. JOURNAL OF UROLOGY, 2019, 201 (04): : E1175 - E1175
  • [35] TISSUE SPECIFIC EXPRESSION OF ANDROGEN RECEPTOR VARIANT 7 IN PROSTATE CANCER PROGRESSION: A POTENTIAL ROLE OF ARV7 IN CARCINOGENESIS
    Bauman, Tyler M.
    Ricke, Emily A.
    Huang, Wei
    Ricke, William A.
    [J]. JOURNAL OF UROLOGY, 2015, 193 (04): : E57 - E58
  • [36] Targeting androgen receptor splice variant 7 in 22Rv1 prostate cancer cells
    Scherbakov, A. M.
    Barysevich, M.
    Laktsevich-Iskryk, M.
    Andreeva, O. E.
    Sorokin, D. V.
    Salnikova, D. I.
    Hurski, A.
    Zhabinskii, V.
    Khripach, V.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S1367 - S1367
  • [37] Expression of Androgen Receptor Splice Variant 7 or 9 in Whole Blood Does Not Predict Response to Androgen-Axis-targeting Agents in Metastatic Castration-resistant Prostate Cancer
    To, Sarah Q.
    Kwan, Edmond M.
    Fettke, Heidi C.
    Mant, Andrew
    Docanto, Maria M.
    Martelotto, Luciano
    Bukczynska, Patricia
    Ng, Nicole
    Graham, Lisa-Jane K.
    Parente, Phillip
    Pezaro, Carmel
    Mahon, Kate
    Horvath, Lisa
    Todenhoefer, Tilman
    Azad, Arun A.
    [J]. EUROPEAN UROLOGY, 2018, 73 (06) : 818 - 821
  • [38] Response of intraductal carcinoma of the prostate to androgen deprivation therapy predicts prostate cancer prognosis in radical prostatectomy patients
    Kato, Masashi
    Hirakawa, Akihiro
    Kobayashi, Yumiko
    Yamamoto, Akiyuki
    Ishida, Ryo
    Kamihira, Osamu
    Sano, Tomoyasu
    Majima, Tsuyoshi
    Ishida, Shohei
    Funahashi, Yasuhito
    Sassa, Naoto
    Fujita, Takashi
    Matsukawa, Yoshihisa
    Hattori, Ryohei
    Gotoh, Momokazu
    Tsuzuki, Toyonori
    [J]. PROSTATE, 2020, 80 (03): : 284 - 290
  • [39] Adjuvant enzalutamide (Enza) for men with non-metastatic high-risk prostate cancer (HRPCa) after radical prostatectomy (RP).
    Ornstein, Moshe Chaim
    Stephenson, Andrew J.
    Elson, Paul
    Tyler, Allison Janine
    Profusek, Pam
    Allman, Kimberly D.
    Barata, Pedro C.
    Magi-Galluzzi, Cristina
    Fergany, Amr Farouk
    Stein, Robert
    Fareed, Khaled
    Haber, Georges-Pascal
    Campbell, Steven C.
    Kaouk, Jihad
    Grivas, Petros
    Rini, Brian I.
    Klein, Eric A.
    Garcia, Jorge A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [40] Androgen Receptor Modulation Optimized for Response-Splice Variant: A Phase 3, Randomized Trial of Galeterone Versus Enzalutamide in Androgen Receptor Splice Variant-7-expressing Metastatic Castration-resistant Prostate Cancer
    Taplin, Mary-Ellen
    Antonarakis, Emmanuel S.
    Ferrante, Karen J.
    Horgan, Kerry
    Blumenstein, Brent
    Saad, Fred
    Luo, Jun
    Bono, Johann S. de
    [J]. EUROPEAN UROLOGY, 2019, 76 (06) : 843 - 851
12345